• Explore /
  • Poster
  • / Randomized phase 2 study of nivolumab with or without ipilimumab in combination with stereotactic body radiotherapy in patients with refractory metastatic pancreatic cancer (CHECKPAC).

Randomized phase 2 study of nivolumab with or without ipilimumab in combination with stereotactic body radiotherapy in patients with refractory metastatic pancreatic cancer (CHECKPAC).

Abstract Poster

Authors

null

Inna Markovna Chen

Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark

Inna Markovna Chen , Julia S. Johansen , Susann Theile , Jessica X. Hjaltelin , Sif I. Novitski , Søren Brunak , Jane P. Hasselby , Gro L. Willemoe , Torben Lorentzen , Kasper Madsen , Benny V. Jensen , Eva E. Wilken , Poul F. Geertsen , Claus Behrens , Christian Nolsoe , Kirstine L. Hermann , Inge Marie Svane , Dorte Nielsen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02866383

DOI

10.1200/JCO.2022.40.4_suppl.554

Abstract #

554

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Alice Markussen

First Author: Chuanliang Cui

First Author: Gauri R. Varadhachary

First Author: Jean-Luc Van Laethem